Oyindamola Christiana Adebayo

Oyindamola Christiana Adebayo

Auto-generated profile, based on publicly available information

Oyindamola Christiana Adebayo

Center for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, 3000 Leuven, Belgium

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2022 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
OAOyindamola C. Adebayo
Oyindamola C. Adebayo
ANAgathe Bikupe Nkoy
Agathe Bikupe Nkoy
LHLambert van den Heuvel
Lambert van den Heuvel
VLVeerle Labarque
Veerle Labarque
ELElena Levtchenko
Elena Levtchenko
HPHans Pottel
Hans Pottel

20 September 2021 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
OAOyindamola Christiana Adebayo
Oyindamola Christiana Adebayo
DBDieuMerci Kabasele Betukumesu
DieuMerci Kabasele Betukumesu
ANAgathe Bikupe Nkoy
Agathe Bikupe Nkoy
OAOluyomi Modupe Adesoji
Oluyomi Modupe Adesoji
PEPepe Mfutu Ekulu
Pepe Mfutu Ekulu
VLVeerle Labarque
Veerle Labarque

29 May 2021 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
OAOyindamola C. Adebayo
Oyindamola C. Adebayo
LHLambert van den Heuvel
Lambert van den Heuvel
WOWasiu A. Olowu
Wasiu A. Olowu
ELElena Levtchenko
Elena Levtchenko
VLVeerle Labarque
Veerle Labarque

15 June 2026 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
OAOyindamola Christiana Adebayo
Oyindamola Christiana Adebayo
Ilhem DallaliIlhem Dallali
Ilhem Dallali
SKSara Kerselaers
Sara Kerselaers
SGSergio Gimeno-Rocafort
Sergio Gimeno-Rocafort
SASandra Van Aerschot
Sandra Van Aerschot
VLVeerle Labarque
Veerle Labarque
Key Points: Apolipoprotein L1 variants were transported to the plasma membrane via actin filaments, where they exhibited distinct dynamics. Apolipoprotein L1 was functionally expressed at the plasma membrane and formed a voltage-dependent non-selective cation-permeable pore. Influx of calcium from the extracellular medium was the primary origin of the increased cytosolic calcium crucial for Apolipoprotein L1 cytotoxicity. Background: The mechanisms by which apolipoprotein L1 ( APOL1 ) risk variants, G1 and G2, induce kidney disease in individuals of African ancestry remain contentious. Methods: In this study, we utilized a heterologous expression system of HEK-293 cells and human podocytes to investigate APOL1-mediated cytotoxicity using genetic, electrophysiological, and microscopy-based approaches. Results: APOL1 variants showed dynamic transport in vesicle-like structures toward the plasma membrane via actin filaments. At the plasma membrane, the non-risk APOL1 G0 and risk variants formed non-selective cation-permeable pores for Na + and Ca 2+ , exhibiting functional activity under basal conditions. Extracellular Ca 2+ was identified as the primary source of Ca 2+ influx through APOL1, leading to cytotoxicity. APOL1 risk variants exhibited increased basal channel activity compared to non-risk APOL1 G0, resulting in haplotype-dependent cytotoxicity. Furthermore, we observed that both the M1 (N264K) variant and APOL1 inhibitor, Inaxaplin, exerted protective effects on cell viability by blocking the APOL1-dependent intracellular Ca 2+ influx. Conclusions: This study demonstrated APOL1 to be a membrane protein involved in the influx of Ca 2+ from the extracellular medium. Increased activity of APOL1 led to markedly increased cytotoxicity, which supports the gain-of-function theory. This effect was prevented by the presence of N264K variant or treatment with the APOL1 inhibitor, Inaxaplin.